Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,033 | -83,736 | -101,870 | -68,239 | -54,630 |
| Depreciation Amortization | -929 | -3,744 | -5,529 | -166 | 3,371 |
| Other Working Capital | -5,403 | -1,300 | 4,706 | -4,459 | 1,226 |
| Other Operating Activity | 10,588 | 14,568 | 21,048 | 14,018 | 7,596 |
| Operating Cash Flow | $-51,777 | $-74,212 | $-81,645 | $-58,846 | $-42,437 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 113 | -29 | -1,805 | -1,578 | -316 |
| Purchase Of Investment | -42,631 | -91,337 | -180,399 | -332,203 | -156,378 |
| Sale Of Investment | 134,981 | 171,794 | 258,250 | 242,389 | 128,250 |
| Investing Cash Flow | $92,463 | $80,428 | $76,046 | $-91,392 | $-28,444 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 9,531 |
| Debt Repayment | -10,650 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 65 | 103 | 638 | 127,861 | 103,054 |
| Financing Cash Flow | $-10,585 | $103 | $638 | $127,861 | $112,585 |
| Exchange Rate Effect | 28 | -63 | -2 | -49 | -50 |
| Beginning Cash Position | 41,749 | 35,493 | 40,456 | 62,882 | 21,228 |
| End Cash Position | 71,878 | 41,749 | 35,493 | 40,456 | 62,882 |
| Net Cash Flow | $30,129 | $6,256 | $-4,963 | $-22,426 | $41,654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,777 | -74,212 | -81,645 | -58,846 | -42,437 |
| Capital Expenditure | -8 | -29 | -1,810 | -1,578 | -316 |
| Free Cash Flow | -51,785 | -74,241 | -83,455 | -60,424 | -42,753 |